{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:40:58Z","timestamp":1784356858388,"version":"3.55.0"},"reference-count":76,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T00:00:00Z","timestamp":1253577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>Weight loss is a primary goal of therapy in overweight patients with type 2 diabetes. This review examines whether positive patient outcomes are observed even after relatively small amounts of weight loss, that is, weight loss being more easily attainable in practice. Clinical studies demonstrate that therapeutic benefit rises with increasing weight loss, but that losses as low as 0.45\u20134 kg (1\u20139 lb) have positive effects on metabolic control, cardiovascular risk factors and mortality rates. Even the intention to lose weight, without significant success, can improve outcomes in patients with diabetes, presumably because of the healthy behaviours associated with the attempt. The current data support a continued focus on weight loss, including moderate weight loss, as a key component of good care for overweight patients with type 2 diabetes.<\/jats:p>","DOI":"10.1111\/j.1463-1326.2009.01155.x","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T10:28:32Z","timestamp":1253615312000},"page":"186-194","source":"Crossref","is-referenced-by-count":50,"title":["Benefits of moderate weight loss in patients with type 2 diabetes"],"prefix":"10.1111","volume":"12","author":[{"given":"Ken","family":"Fujioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,31]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.6.667"},{"key":"e_1_2_8_3_2","first-page":"177","article-title":"Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes","volume":"4","author":"DeFronzo RA.","year":"1997","journal-title":"Diabetes Rev"},{"key":"e_1_2_8_4_2","first-page":"366","article-title":"Effects of weight loss on glucose homeostasis in NIDDM","volume":"3","author":"Kelley DE.","year":"1995","journal-title":"Diabetes Rev"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0843"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010492"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2006.09.020"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.11.1744"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.9.1278"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0560"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370100063012"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400070100012"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.10.1499"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00709.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2007.05.015"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030133"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2006.179"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.3.316"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.11.2703"},{"key":"e_1_2_8_21_2","unstructured":"IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation 2005."},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S013"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.13.S1.1"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.62.3.220"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.32.s3.4.x"},{"key":"e_1_2_8_26_2","article-title":"Adipose tissue dysfunction in obesity, diabetes, and vascular diseases","author":"Hajer GR","year":"2008","journal-title":"Eur Heart J"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05482"},{"issue":"6","key":"e_1_2_8_28_2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1042\/bst0311115","article-title":"The glucose\u2010fatty acid cycle: a physiological perspective","volume":"31","author":"Frayn KN.","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91500-9"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.5.677"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"e_1_2_8_33_2","first-page":"CD004095","article-title":"Long\u2010term non\u2010pharmacologic weight loss interventions for adults with type 2 diabetes","volume":"2","author":"Norris SL","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.6.995"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1207\/S15327558IJBM0801_03"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1988.tb01050.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1987.tb10679.x"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(93)90118-O"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2003.10719316"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2006.10.003"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2006.031"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-002-0084-4"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2295"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2487"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(03)00064-3"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1249\/mss.0b013e31815614cb"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0048"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.6.703"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39385.413113.25"},{"key":"e_1_2_8_51_2","unstructured":"Sanofi\u2010aventis.Sanofi\u2010aventis to Discontinue all Clinical Trials with Rimonabant: Press Release. Available from URL:www.sanofi\u2010aventis.us\/live\/us\/en\/index.jsp. Accessed 20 December 2008."},{"key":"e_1_2_8_52_2","first-page":"CD004096","article-title":"Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus","volume":"1","author":"Norris SL","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_53_2","unstructured":"Prozac [package insert]. Indianapolis IN: Eli Lilly and Company; 2009."},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.942"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2000.00081.x"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00022"},{"issue":"7","key":"e_1_2_8_57_2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00024","article-title":"Body weight change, all\u2010cause mortality, and cause\u2010specific mortality in the Multiple Risk Factor Intervention Trial","volume":"119","author":"Blair SN","year":"1993","journal-title":"Ann Intern Med"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.6.766"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)00217-E"},{"issue":"4","key":"e_1_2_8_60_2","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1111\/j.1753-4887.1996.tb03906.x","article-title":"Is weight loss hazardous?","volume":"54","author":"Lee IM","year":"1996","journal-title":"Nutr Rev"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106273242602"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-789X.2003.00090.x"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-789X.2003.00092.x"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.657"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800875"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730120-00005"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200302010-00004"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01003.x"},{"key":"e_1_2_8_69_2","first-page":"CD002966","article-title":"Metformin monotherapy for type 2 diabetes mellitus","volume":"3","author":"Saenz A","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.2.194"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2003.00295.x"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0804182"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.53.1.111"},{"key":"e_1_2_8_76_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806359"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2009.01155.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2009.01155.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:40:59Z","timestamp":1761882059000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2009.01155.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,31]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1463-1326.2009.01155.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01155.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,31]]}}}